12 Feb 2026 Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA Download
5 Feb 2026 Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary Download
12 Jan 2026 Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Download
19 Dec 2025 Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Download
24 Nov 2025 Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business Download